Regeneron Pharmaceuticals (REGN) Income from Non-Controlling Interests (2017 - 2019)

Regeneron Pharmaceuticals' Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at -$1.0 million for Q1 2019.

• In Q1 2019, Income from Non-Controlling Interests fell 171.43% year-over-year to -$1.0 million; the TTM figure through Mar 2019 stood at -$1.8 million (down 181.82% YoY), while the FY2018 annual figure was $700000.0, down 12.5% from the prior year.
• Income from Non-Controlling Interests for Q1 2019 stood at -$1.0 million, up from -$1.7 million in the prior quarter.
• The five-year high for Income from Non-Controlling Interests was $1.4 million in Q1 2018, with the low at -$1.7 million in Q4 2018.
• The 3-year median for Income from Non-Controlling Interests is $164000.0 (2017), against an average of $50000.0.
• Peak annual rise in Income from Non-Controlling Interests reached 14900.0% in 2018, while the deepest fall reached 320.78% in 2018.
• Regeneron Pharmaceuticals' Income from Non-Controlling Interests stood at $770000.0 in 2017, then sank by 320.78% to -$1.7 million in 2018, then soared by 41.18% to -$1.0 million in 2019.
• Business Quant data shows REGN's Income from Non-Controlling Interests at -$1.0 million in Q1 2019, -$1.7 million in Q4 2018, and $300000.0 in Q3 2018.